HIGH UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN ACUTE NONLYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
FRADE, LJG [1 ]
AVELLO, AG [1 ]
SUREDA, A [1 ]
LARANA, JG [1 ]
TORRADO, MC [1 ]
机构：
[1] UNIV ALCALA DE HENARES, HOSP RAMON & CAJAL, DEPT HEMATOL, ALCALA DE HENARES, SPAIN
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1336 / 1336
页数：1
相关论文
共 50 条
  • [21] INVITRO STUDIES ON THE BINDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND UROKINASE (U-PA) TO LIVER MEMBRANES
    KALYAN, NK
    LEE, SG
    HUM, WT
    HARTZELL, R
    LEVNER, M
    HUNG, PP
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 217 - 217
  • [22] LEVEL OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ANTIGEN REFLECTS NEOPLASTIC POTENTIAL OF COLORECTAL MUCOSA
    SKELLY, MM
    MULCAHY, HE
    CONNELL, T
    TROY, A
    DUGGAN, C
    DUFFY, MJ
    SHEHAN, K
    ODONOHUGHE, DP
    GASTROENTEROLOGY, 1995, 108 (04) : A539 - A539
  • [23] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ANTIGEN IS A PREDICTOR OF EARLY RELAPSE IN BREAST-CANCER
    JANICKE, F
    SCHMITT, M
    HAFTER, R
    HOLLRIEDER, A
    BABIC, R
    ULM, K
    GOSSNER, W
    GRAEFF, H
    FIBRINOLYSIS, 1990, 4 (02) : 69 - 78
  • [24] High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma
    Borgfeldt, C
    Casslén, B
    Liu, CL
    Hansson, S
    Lecander, I
    Åstedt, B
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (06) : 588 - 595
  • [25] STAUROSPORINE STIMULATES EXPRESSION OF THE UROKINASE-TYPE (U-PA) PLASMINOGEN-ACTIVATOR IN LLC-PK1 CELLS
    DIERKSVENTLING, C
    KNESEL, J
    NAGAMINE, Y
    HEMMINGS, BA
    PEHLING, G
    FISCHER, F
    FABBRO, D
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) : 865 - 870
  • [26] Thrombin stimulation of platelets induces plasminogen activation mediated by urokinase type plasminogen activator (u-PA)
    Lenich, C
    Liu, JN
    Gurewich, V
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3073 - P3073
  • [27] Expression of urokinase type plasminogen activator (u-PA) and U-PA inhibitor (PAI-1) in lung cancers: Clinical significance
    Brambilla, E
    Robert, C
    Bolon, I
    Decaussin, M
    LABORATORY INVESTIGATION, 1999, 79 (01) : 181A - 181A
  • [28] CONSTRUCTION AND EXPRESSION OF A HYBRID PLASMINOGEN-ACTIVATOR GENE WITH SEQUENCES FROM NON-PROTEASE REGION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PROTEASE REGION OF UROKINASE (U-PA)
    KALYAN, NK
    LEE, SG
    CHENG, SM
    HARTZELL, R
    URBANO, C
    HUNG, PP
    GENE, 1988, 68 (02) : 205 - 212
  • [29] THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PALSMINOGEN ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION
    HIBINO, T
    OONUMA, M
    TAKAHASHI, T
    HORII, I
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 633 - 633
  • [30] Comparison of the inhibition of urokinase-type plasminogen activator (u-PA) activity by monoclonal antibodies specific for u-PA as assessed by different assays
    vanBoheemen, PA
    vandenHoogen, CM
    Koolwijk, P
    FIBRINOLYSIS, 1995, 9 (06) : 343 - 349
12345